Scarica l'app Stockscreener
7.96
2.09%
-0.17
Dopo l'orario di chiusura:
8.11
0.15
+1.88%
Precedente Chiudi:
$8.13
Aprire:
$8.11
Volume 24 ore:
857.22K
Relative Volume:
0.67
Capitalizzazione di mercato:
$620.44M
Reddito:
$400.05M
Utile/perdita netta:
$181.01M
Rapporto P/E:
3.7917
EPS:
2.0993
Flusso di cassa netto:
$194.58M
1 W Prestazione:
-6.02%
1M Prestazione:
+5.71%
6M Prestazione:
+18.45%
1 anno Prestazione:
-37.76%
Intervallo 1D:
$7.92
$8.12
Intervallo di 1 settimana:
$7.92
$8.605
Portata 52W:
$6.125
$13.34
CorMedix Inc Stock (CRMD) Company Profile
Nome
CorMedix Inc
Settore
Industria
Telefono
908-517-9500
Indirizzo
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Compare CRMD vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
7.96 | 633.69M | 400.05M | 181.01M | 194.58M | 2.0993 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2025-06-30 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-07 | Iniziato | Leerink Partners | Outperform |
| 2025-01-13 | Iniziato | D. Boral Capital | Buy |
| 2024-08-26 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-02-17 | Iniziato | Needham | Buy |
| 2020-09-29 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-09-21 | Iniziato | Truist | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2019-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2018-12-06 | Iniziato | ROTH Capital | Buy |
| 2017-09-25 | Reiterato | H.C. Wainwright | Buy |
| 2017-08-10 | Reiterato | Rodman & Renshaw | Buy |
| 2017-05-05 | Reiterato | Rodman & Renshaw | Buy |
| 2016-11-11 | Reiterato | FBR & Co. | Outperform |
| 2016-03-17 | Reiterato | FBR Capital | Outperform |
| 2016-03-03 | Iniziato | FBR Capital | Outperform |
| 2015-11-16 | Reiterato | ROTH Capital | Neutral |
| 2015-10-29 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Downgrade | ROTH Capital | Buy → Neutral |
| 2014-12-08 | Reiterato | ROTH Capital | Buy |
| 2011-10-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
CorMedix Inc Borsa (CRMD) Ultime notizie
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
CorMedix at Wells Fargo 21st annual healthcare conference: growth, risk By Investing.com - Investing.com Canada
CorMedix Inc. (CRMD) Latest Stock News & Headlines - Yahoo Finance
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged - Yahoo Finance
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet - Yahoo Finance
Bank of New York Mellon Corp Takes Position in CorMedix Inc $CRMD - MarketBeat
CRMD Stock Soared 18% Today – Here’s What Fueled CorMedix’s Triple-Digit Q1 Revenue Surge - Stocktwits
CRMD Stock Jumps As Antifungal Drug Clears Key Trial For $2B Preventive Market - Stocktwits
The Technical Signals Behind (CRMD) That Institutions Follow - Stock Traders Daily
Cormedix Stock Price Forecast. Should You Buy CRMD? - StockInvest.us
CorMedix Inc (NASDAQ: CRMD) Share Price, CRMD Stock News, CRMD Share Price & Updates - kalkine.ca
243,232 Shares in CorMedix Inc $CRMD Purchased by Empowered Funds LLC - MarketBeat
CRMD|CorMedix Inc|Price:8.430|Chg%:-0.040 - TradingKey
CorMedix (CRMD) COO holds 270K shares after cost-covering share withholding - Stock Titan
CorMedix will meet investors in Boston for a Wells Fargo chat - Stock Titan
BlackRock Inc. Acquires Shares of 6,324,111 CorMedix Inc $CRMD - MarketBeat
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference - Yahoo Finance
CorMedix (CRMD) Upgraded to Buy: Here's Why - Yahoo Finance
CorMedix (CRMD) CFO uses shares to cover taxes - Stock Titan
CRMD's Growth Story Expands Beyond DefenCath Into New Trends - Eastern Progress
CorMedix (CRMD) Results at a Glance: EPS Exceeds Its Estimate in Latest Trading; Shares Move Lower 0.72% on the DayTech Earnings Analysis - vinanet.vn
CorMedix (CRMD) Q2 2026 Earnings Call Transcript - AOL.com
Wall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to Trade - Yahoo Finance
CorMedix (CRMD) Momentum: Moves 0.12% Up to $8.18 in the Current Update; Range View: Traders Can Monitor the $7.77-$8.59 Range in Latest TradingETF Creation Redemption - vinanet.vn
CorMedix (CRMD) Price Action: Ends Up by 6.19% at $8.14 on the Day; Chart Reference: the Near-Term Reference Band Stretches From $7.73 to $8.55 in the Latest SessionReversal Setup Alerts - Vinanet
Research Analysts Set Expectations for CorMedix Q3 Earnings - MarketBeat
CRMD Q2 2026 Earnings: EPS of $0.29 Beats Consensus by 19.4%EPS Guidance Update - Vinanet
CorMedix: Durable Commercial Base, But 2027 Is The Real Test (NASDAQ:CRMD) - Seeking Alpha
CorMedix (NASDAQ:CRMD) Shares Up 7.3% on Analyst Upgrade - MarketBeat
FY2026 EPS Estimates for CorMedix Raised by HC Wainwright - MarketBeat
(CRMD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CorMedix Inc (CRMD) Stock News Today - TradingKey
CorMedix Stock Jumps on Strong DefenCath Sales - Sahm
Full Transcript: Cormedix Q2 2026 Earnings Call - Sahm
CorMedix (NASDAQ:CRMD) Shares Down 4.6%Here's Why - MarketBeat
Royal Bank Of Canada Issues Positive Forecast for CorMedix (NASDAQ:CRMD) Stock Price - MarketBeat
CorMedix's New Major DefenCath Customer Backs 2026 Volumes, Durability Through 2027, RBC Says - marketscreener.com
CRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta Gains - The Globe and Mail
RBC Adjusts Price Target on CorMedix to $14 From $13, Maintains Outperform Speculative Risk Rating - Moomoo
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
H.C. Wainwright reiterates CorMedix stock rating on strong quarter - Investing.com
H.C. Wainwright reiterates CorMedix stock rating on strong quarter By Investing.com - Investing.com India
H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13 - Moomoo
CorMedix (CRMD) Q2 2026 Earnings Call: Revenue Hits $101.9M, EBITDA Guidance Raised - TradingKey
CorMedix (CRMD) Stock Drops As Raised Outlook Fails To Soothe Risk Concerns - webull.com
CorMedix Inc (NASDAQ:CRMD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CorMedix Inc Azioni (CRMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):